Patents | Intellepedia

Dr. Kalyan C. Kankanala delivers a session on Patent Licensing to students at National Law School of India University, Bangalore

[slideshare id=249346522&doc=patentlicensing-210614051209]

Updated Patent, Trade Mark, Copyright and other Acts

The post offers updated and amended versions of major Indian intellectual property statutes following the abolition of the IPAB. Downloadable resources and detailed amendment summaries are provided for reference.

In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis for compulsory licensing and argues for its strategic use to ensure public access to vaccines and medicines.

Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

Natco Pharma has withdrawn its compulsory license application for Baricitinib following an agreement with Eli Lilly. The Indian Patent Office has extended procedural deadlines, and other significant updates in IP law are discussed, including ongoing litigation and international proposals.

Free Master Class on IP for Start Ups, Entrepreneurs and SMEs

BananaIP and NASSCOM present a free master class on intellectual property for startups, entrepreneurs, and SMEs. Participants will gain essential insights on protecting and commercializing their innovations, with expert-led sessions focusing on patents and IP strategies.

Natco files compulsory license request; USA approves temporary patent waiver; Ericsson and Samsung settle dispute and more

Natco seeks a compulsory license for Baricitinib, while the USA backs a temporary COVID-19 vaccine patent waiver. The EU critiques the US approach, and Ericsson and Samsung resolve their ongoing patent dispute. WIPO also releases a new guide on industrial design registration.

Supreme Court restores order extending time limits indefinitely, asks why Government is not invoking compulsory licensing provisions and more

The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government’s approach to compulsory licensing of essential medicines. India also features on the US Special 301 Report’s Priority Watch List, while the USPTO is hosting free design patent webinars.

Delhi High Court asks government to consider issuing compulsory licenses, World IP day 2021, a solemn affair this year, India – South Africa patent waiver proposal opposed again and more

The Delhi High Court has advised the government to consider compulsory licensing of COVID-19 treatments, reflecting the urgent need for wider access. This post also covers the global debate on patent waivers and the observance of World IP Day 2021, with a focus on recent legal and policy updates.

Nokia and Lenovo settle patent dispute, Apple wins $506 Million patent-damages appeal and more

This post provides an analytical overview of recent patent disputes and policy developments. It discusses the Nokia-Lenovo settlement, Apple’s patent damages appeal, and new USPTO initiatives related to COVID-19, offering a legal perspective on each event.

Vitiation of IPAB and Beyond – Changes to the Indian Patents Act

The abolition of the IPAB has shifted appellate and adjudicatory functions under the Indian Patents Act to the High Courts. This post analyses the significant legal changes, outlining the expanded role of Indian High Courts in patent matters after the Tribunals Reforms Ordinance 2021.